Eastgate Biotech Corp.
ETBI · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $14,477 | $6,625 | $1,112 | $9,753 |
| - Cash | $10 | $4 | $16 | -$50 |
| + Debt | $4,505 | $3,953 | $3,126 | $1,716 |
| Enterprise Value | $18,972 | $10,574 | $4,222 | $11,520 |
| Revenue | $100 | $136 | $157 | $0 |
| % Growth | -26.7% | -13.5% | – | – |
| Gross Profit | -$110 | -$69 | -$3 | $0 |
| % Margin | -110.4% | -50.6% | -1.9% | – |
| EBITDA | -$3,099 | -$1,235 | -$3,329 | -$2,579 |
| % Margin | -3,107.2% | -907.2% | -2,115% | – |
| Net Income | -$3,544 | -$1,498 | -$3,719 | -$2,977 |
| % Margin | -3,553.7% | -1,100.3% | -2,363.4% | – |
| EPS Diluted | -0.002 | -0.001 | 0 | -0.01 |
| % Growth | -58.3% | – | 100% | – |
| Operating Cash Flow | $114 | -$258 | -$1,396 | -$389 |
| Capital Expenditures | -$54 | $0 | -$48 | $0 |
| Free Cash Flow | $60 | -$258 | -$1,443 | -$389 |